Approval · Notice of Compliance 5482 · 1994
TAZOCIN: Notice of Compliance 5482
Issued April 7, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5482
- Date
- April 7, 1994
- Company
- Lederle Cyanamid Canada Inc.St-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antibiotic, B-lactamase inhibitor
Products in this notice
Medicinal ingredients
- TAZOBACTAM SODIUM 0.5 G per VIAL
- PIPERACILLIN SODIUM 4 G per VIAL
- PIPERACILLIN SODIUM 2 G per VIAL
- TAZOBACTAM SODIUM 0.25 G per VIAL
- PIPERACILLIN SODIUM 3 G per VIAL
- TAZOBACTAM SODIUM 0.375 G per VIAL